Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019-2020
Por:
Morillo-Verdugo R, Robustillo-Cortes MLA, Navarro-Ruiz A, Sánchez-Rubio Ferrandez J, Fernández Espínola S, Fernández-Pacheco García-Valdecasas M and Vélez-Diaz-Pallares M
Publicada:
1 ene 2022
Ahead of Print:
24 may 2022
Resumen:
Background: People living with HIV (PLWH) have significantly enhanced their life expectancy. Consequently, age-associated comorbidities and related health conditions are increasingly found in PLWH complicating their clinical management.
Objective: To determine the effect of the capacity-motivation-opportunity (CMO) structured pharmaceutical care intervention for improving clinical health-care results frequently associated to PLWH.
Methods: Multicenter, prospective, pre-post intervention study evaluating the CMO pharmacist-led program in adult PLWH was conducted between September 2019 and September 2020 with six months of follow-up. The primary objective of this study was to determine differences in clinical outcomes (total cholesterol, triglycerides, HDL, blood pressure and glycosylated hemoglobin) and variation in the patient's activation measure before and after the intervention.
Results: A total of 61 patients were included, 72% were men with a median age of 53 years. After the implementation of the pharmacist-driven program, the percentage of patients with high levels of total cholesterol decreased significantly (18% to 4.9%; p < 0.001). Similarly, the prevalence of patients with high levels of triglycerides, HDL or with hypertension was significantly lower post intervention (13.1% to 6.6%, p < 0.001; 47.5% to 6.6%, p = 0.019 and 24% to 4%, p = 0.009, respectively). The number of patients who achieved the highest activation level increased from 69% to 77.6% (p < 0.001).
Conclusion: The CMO program resulted in significantly better health outcomes during the six months following the pharmacist-led intervention as well as improved activation in PLWH.
Filiaciones:
Morillo-Verdugo R:
Pharmacy Hospital Service, Hospital Valme, Área de Gestión Sanitaria Sur de Sevilla, Sevilla, Spain
Robustillo-Cortes MLA:
Pharmacy Hospital Service, Hospital Juan Ramón Jiménez, Huelva, Spain
:
Pharmacy Hospital Service, Hospital de Elche, Alicante, Spain
Sánchez-Rubio Ferrandez J:
Pharmacy Hospital Service, Hospital de Getafe, Madrid, Spain
Fernández Espínola S:
Pharmacy Hospital Service, Hospital Serranía de Ronda, Málaga, Spain
Fernández-Pacheco García-Valdecasas M:
Pharmacy Hospital Service, Hospital Príncipe de Asturias, Madrid, Spain
Vélez-Diaz-Pallares M:
Pharmacy Hospital Service, Hospital Ramón y Cajal, Madrid, Spain
Green Published, gold
|